Landmarks across Canada will glow blue in November for Eczema Awareness Month
Lockton Canada’s first market update hands plan sponsors a rare window to rein in drug spending
Supplement deals hit US$14.6 billion through October as US regulators weigh new dietary ingredient rules
Towards Healthcare values the global GLP-1 market rising to US$130 billion by 2035
Regulation 552 now mirrors a 2011 policy the province says shields $5.2 billion in OHIP costs
Bill 11 took effect October 1, and also bars employers from cutting drug benefits by age
